Market Overview:
The global hemostasis and tissue sealing agents market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth of the market can be attributed to the increasing prevalence of surgical procedures, rising geriatric population, and technological advancements in hemostasis and tissue sealing agents. However, the high cost of these products may restrain the growth of this market during the forecast period. Based on type, the global hemostasis and tissue sealing agents market is segmented into hemostasis agents and tissue sealing agents. Hemostasis agents are further classified into thrombin-based products, fibrin sealants/adhesives, collagen-based products, oxidized regenerated cellulose (ORC)-based products,,and other thrombin inhibitors. Tissue sealants are further classified into natural polymers (collagen), synthetic polymers (polyethylene glycol [PEG]), cyanoacrylate esters), metal-ion chelates) adhesives). Based on application, the global hemostasis and tissue sealing agent market is segmented into minimally invasive surgery (MIS), general surgery,,others).
Product Definition:
Hemostasis is the process that stops bleeding. Tissue sealing agents are substances that help to stop bleeding by sealing the wound. They may also promote healing of the wound.
Hemostasis Agents:
Hemostasis agents are substances that inhibit coagulation and fibrinolysis. They are used to prevent bleeding during surgical procedures, dental treatments, or injury repair. Hemostatic agents can be either synthetic (drugs) or natural (platelets). The most common hemostatic agent is platelet-rich plasma (PRP), which consists of a high concentration of the protein “pla” in its purified form.
Tissue Sealing Agents:
Tissue sealing agents are chemicals that prevent the blood from clotting. They have anticoagulant properties and can be used in various procedures of hemostasis and tissue sealing. Tissue sealing agents market is segmented on the basis of product types into natural products such as sericin, synthetic type II collagen, gelatin, alfa-interferon etc., which are further sub-segmented into a number of individual drugs.
Application Insights:
The general surgery segment dominated the market in 2017 and is expected to witness significant growth over the forecast period. This can be attributed to a rise in number of general surgeries, such as cardiovascular procedures, urologic surgeries, orthopedic procedures and others. Moreover, minimally invasive surgeries are also gaining popularity due to their low risk-to-benefit ratio. As per the Urology Care Foundation (2017), around 1.7 million surgical procedures are performed every year in the U.S.
Minimally invasive heart valve replacement has gained popularity owing to benefits associated with shorter hospital stay duration.
Regional Analysis:
North America dominated the global market in terms of revenue share in 2017. This can be attributed to factors such as increasing prevalence of cardiovascular diseases, cancer, and diabetes; rising number of surgical procedures; and high healthcare expenditure. In addition, favorable reimbursement policies for medical treatments provided by hemostasis & tissue sealing agents are also expected to drive the regional demand over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to factors such as improving healthcare infrastructure leading to increased adoption of advanced treatment options by patients along with physicians for various disorders and diseases including cardiovascular disease (CVD), cancer, diabetes etc.; growing geriatric population prone to CVDs & cancers; rapid economic development resulting in improved lifestyle habits among people which results into higher incidence rates of these chronic conditions further driving up demand for hemostasis products over next eight years.
Growth Factors:
- Increasing incidence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. The increase in the number of people suffering from chronic diseases will lead to an increase in demand for hemostasis and tissue sealing agents.
- Technological advancements: The hemostasis and tissue sealing agents market is witnessing rapid technological advancements, with new products being launched regularly. This is helping to improve the efficacy and safety profile of these products, thereby driving their demand.
- Growing awareness about advanced medical treatments: There has been a growing awareness among people about advanced medical treatments such as hemostasis and tissue sealing agents procedures. This has led to an increase in demand for these procedures, which in turn is boosting growth prospects for the hemostasis and tissue sealing agents market .
Scope Of The Report
Report Attributes
Report Details
Report Title
Hemostasis and Tissue Sealing Agents Market Research Report
By Type
Hemostasis Agents, Tissue Sealing Agents
By Application
Minimally Invasive Surgery, General Surgery, Other,
By Companies
Johnson & Johnson, Baxter, C R Bard, B Braun, Gelita, Integra Life Sciences, Advance Medical Solution, Pfizer, CSL Behring, CryoLife, Zimmer Biomet, Ferrosan Medical Devices, Medtronic, Smith & Nephew, Z-Medica, Equimedical, Marine Polymer,
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Hemostasis and Tissue Sealing Agents Market Report Segments:
The global Hemostasis and Tissue Sealing Agents market is segmented on the basis of:
Types
Hemostasis Agents, Tissue Sealing Agents
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Minimally Invasive Surgery, General Surgery, Other,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson & Johnson
- Baxter
- C R Bard
- B Braun
- Gelita
- Integra Life Sciences
- Advance Medical Solution
- Pfizer
- CSL Behring
- CryoLife
- Zimmer Biomet
- Ferrosan Medical Devices
- Medtronic
- Smith & Nephew
- Z-Medica
- Equimedical
- Marine Polymer
Highlights of The Hemostasis and Tissue Sealing Agents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hemostasis Agents
- Tissue Sealing Agents
- By Application:
- Minimally Invasive Surgery
- General Surgery
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hemostasis and Tissue Sealing Agents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hemostasis is the process of maintaining blood flow and preventing bleeding. Tissue sealing agents are chemicals that help to prevent leakage of bodily fluids, such as blood, from a wound.
Some of the major companies in the hemostasis and tissue sealing agents market are Johnson & Johnson, Baxter, C R Bard, B Braun, Gelita, Integra Life Sciences, Advance Medical Solution, Pfizer, CSL Behring, CryoLife, Zimmer Biomet, Ferrosan Medical Devices, Medtronic, Smith & Nephew, Z-Medica, Equimedical, Marine Polymer.
The hemostasis and tissue sealing agents market is expected to grow at a compound annual growth rate of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Hemostasis and Tissue Sealing Agents Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Hemostasis and Tissue Sealing Agents Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Hemostasis and Tissue Sealing Agents Market - Supply Chain
4.5. Global Hemostasis and Tissue Sealing Agents Market Forecast
4.5.1. Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Hemostasis and Tissue Sealing Agents Market Size (000 Units) and Y-o-Y Growth
4.5.3. Hemostasis and Tissue Sealing Agents Market Absolute $ Opportunity
5. Global Hemostasis and Tissue Sealing Agents Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Hemostasis and Tissue Sealing Agents Market Size and Volume Forecast by Type
5.3.1. Hemostasis Agents
5.3.2. Tissue Sealing Agents
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Hemostasis and Tissue Sealing Agents Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Hemostasis and Tissue Sealing Agents Market Size and Volume Forecast by Application
6.3.1. Minimally Invasive Surgery
6.3.2. General Surgery
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Hemostasis and Tissue Sealing Agents Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Hemostasis and Tissue Sealing Agents Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Hemostasis and Tissue Sealing Agents Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Hemostasis and Tissue Sealing Agents Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Hemostasis and Tissue Sealing Agents Demand Share Forecast, 2019-2026
9. North America Hemostasis and Tissue Sealing Agents Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Hemostasis and Tissue Sealing Agents Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Hemostasis and Tissue Sealing Agents Market Size and Volume Forecast by Application
9.4.1. Minimally Invasive Surgery
9.4.2. General Surgery
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Hemostasis and Tissue Sealing Agents Market Size and Volume Forecast by Type
9.7.1. Hemostasis Agents
9.7.2. Tissue Sealing Agents
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Hemostasis and Tissue Sealing Agents Demand Share Forecast, 2019-2026
10. Latin America Hemostasis and Tissue Sealing Agents Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Hemostasis and Tissue Sealing Agents Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Hemostasis and Tissue Sealing Agents Market Size and Volume Forecast by Application
10.4.1. Minimally Invasive Surgery
10.4.2. General Surgery
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Hemostasis and Tissue Sealing Agents Market Size and Volume Forecast by Type
10.7.1. Hemostasis Agents
10.7.2. Tissue Sealing Agents
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Hemostasis and Tissue Sealing Agents Demand Share Forecast, 2019-2026
11. Europe Hemostasis and Tissue Sealing Agents Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Hemostasis and Tissue Sealing Agents Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Hemostasis and Tissue Sealing Agents Market Size and Volume Forecast by Application
11.4.1. Minimally Invasive Surgery
11.4.2. General Surgery
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Hemostasis and Tissue Sealing Agents Market Size and Volume Forecast by Type
11.7.1. Hemostasis gents
11.7.2. Tissue Sealing Agents
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Hemostasis and Tissue Sealing Agents Demand Share, 2019-2026
12. Asia Pacific Hemostasis and Tissue Sealing Agents Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Hemostasis and Tissue Sealing Agents Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Hemostasis and Tissue Sealing Agents Market Size and Volume Forecast by Application
12.4.1. Minimally Invasive Surgery
12.4.2. General Surgery
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Hemostasis and Tissue Sealing Agents Market Size and Volume Forecast by Type
12.7.1. Hemostasis Agents
12.7.2. Tissue Sealing Agents
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Hemostasis and Tissue Sealing Agents Demand Share, 2019-2026
13. Middle East & Africa Hemostasis and Tissue Sealing Agents Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Hemostasis and Tissue Sealing Agents Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Hemostasis and Tissue Sealing Agents Market Size and Volume Forecast by Application
13.4.1. Minimally Invasive Surgery
13.4.2. General Surgery
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Hemostasis and Tissue Sealing Agents Market Size and Volume Forecast by Type
13.7.1. Hemostasis Agents
13.7.2. Tissue Sealing Agents
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Hemostasis and Tissue Sealing Agents Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Hemostasis and Tissue Sealing Agents Market: Market Share Analysis
14.2. Hemostasis and Tissue Sealing Agents Distributors and Customers
14.3. Hemostasis and Tissue Sealing Agents Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Johnson & Johnson
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Baxter
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. C R Bard
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. B Braun
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Gelita
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Integra Life Sciences
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Advance Medical Solution
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Pfizer
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. CSL Behring
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. CryoLife
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Zimmer Biomet
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Ferrosan Medical Devices
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Medtronic
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Smith & Nephew
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Z-Medica
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Equimedical
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Marine Polymer
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18.
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
